Up-regulation of tumor necrosis factor α mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection

被引:29
作者
Kabeya, H
Ohashi, K
Oyunbileg, N
Nagaoka, Y
Aida, Y
Sugimoto, C
Yokomizo, Y
Onuma, M [1 ]
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan
[2] RIKEN, Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Tsukuba, Ibaraki 3050074, Japan
[3] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan
关键词
bovine-leukemia virus; cytokines; peptide vaccine; tumor necrosis factor alpha;
D O I
10.1016/S0165-2427(99)00029-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protective immune responses were analyzed in eight sheep vaccinated with BLV envelope peptides and experimentally infected with bovine-leukemia virus (BLV). Five of eight peptide-immunized sheep showed a high T-cell proliferative response to the BLV peptides and all of these were protected from the infection. The other three peptide-immunized sheep showed no T-cell proliferative responses to any BLV antigens similar to control sheep, though they also exhibited resistance to BLV challenge. To investigate other mechanisms which suppress BLV expansion in these non-responding sheep, we measured the levels of the cytokine expressions before, and after, BLV challenge using competitive reverse-transcriptase polymerase chain-reaction systems. It was revealed that the expression of tumor necrosis factor alpha (TNF alpha) was higher in BLV-resistant sheep than in BLV-susceptible sheep. Thus, TNF alpha expression rather than specific T-cell activity may play an important role in the protective mechanism against BLV infection, at least during the primary viremia phase. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:255 / 265
页数:11
相关论文
共 30 条
  • [11] ENDOTOXIN-RESPONSIVE SEQUENCES CONTROL CACHECTIN TUMOR NECROSIS FACTOR BIOSYNTHESIS AT THE TRANSLATIONAL LEVEL
    HAN, J
    BROWN, T
    BEUTLER, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) : 465 - 475
  • [12] IMMUNOSUPPRESSIVE RETROVIRAL PEPTIDES - CAMP AND CYTOKINE PATTERNS
    HARAGUCHI, S
    GOOD, RA
    DAY, NK
    [J]. IMMUNOLOGY TODAY, 1995, 16 (12): : 595 - 603
  • [13] Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: Low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load
    Hestdal, K
    Aukrust, P
    Muller, F
    Lien, E
    Bjerkeli, V
    Espevik, T
    Froland, SS
    [J]. BLOOD, 1997, 90 (07) : 2670 - 2679
  • [14] An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infested cells in carrier sheep
    Kabeya, H
    Ohashi, K
    Ohishi, K
    Sugimoto, C
    Amanuma, H
    Onuma, M
    [J]. VACCINE, 1996, 14 (12) : 1118 - 1122
  • [15] A NOVEL FORM OF TNF/CACHECTIN IS A CELL-SURFACE CYTO-TOXIC TRANSMEMBRANE PROTEIN - RAMIFICATIONS FOR THE COMPLEX PHYSIOLOGY OF TNF
    KRIEGLER, M
    PEREZ, C
    DEFAY, K
    ALBERT, I
    LU, SD
    [J]. CELL, 1988, 53 (01) : 45 - 53
  • [16] ASSOCIATION BETWEEN BOLA AND SUBCLINICAL BOVINE LEUKEMIA-VIRUS INFECTION IN A HERD OF HOLSTEIN-FRIESIAN COWS
    LEWIN, HA
    WU, MC
    STEWART, JA
    NOLAN, TJ
    [J]. IMMUNOGENETICS, 1988, 27 (05) : 338 - 344
  • [17] MATHEISE JP, 1992, LEUKEMIA, V6, P304
  • [18] VARIATION IN THE TNF-ALPHA PROMOTER REGION ASSOCIATED WITH SUSCEPTIBILITY TO CEREBRAL MALARIA
    MCGUIRE, W
    HILL, AVS
    ALLSOPP, CEM
    GREENWOOD, BM
    KWIATKOWSKI, D
    [J]. NATURE, 1994, 371 (6497) : 508 - 511
  • [19] PROTECTIVE IMMUNITY AGAINST BOVINE LEUKEMIA-VIRUS (BLV) INDUCED IN CARRIER SHEEP BY INOCULATION WITH A VACCINIA VIRUS-BLV ENV RECOMBINANT - ASSOCIATION WITH CELL-MEDIATED-IMMUNITY
    OHISHI, K
    SUZUKI, H
    YAMAMOTO, T
    MARUYAMA, T
    MIKI, K
    IKAWA, Y
    NUMAKUNAI, S
    OKADA, K
    OHSHIMA, K
    SUGIMOTO, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1887 - 1892
  • [20] Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome
    Ohishi, K
    Kabeya, H
    Amanuma, H
    Onuma, M
    [J]. VACCINE, 1996, 14 (12) : 1143 - 1148